KMB
30
2
AFL
37
3
JWN
50
4
WY
37
7
PPG
49
2
EOG
50
4
PLD
35
3
HST
37
2
HPE
51
-2
ADM
33
2
WYNN
29
3
NDAQ
55
3
ZBH
59
-12
FMC
30
7
NAVI
24
2
FSLR
49
-3
DG
2
-14
AMP
46
2
RIG
43
2
XEL
39
3
KMB
30
2
AFL
37
3
JWN
50
4
WY
37
7
PPG
49
2
EOG
50
4
PLD
35
3
HST
37
2
HPE
51
-2
ADM
33
2
WYNN
29
3
NDAQ
55
3
ZBH
59
-12
FMC
30
7
NAVI
24
2
FSLR
49
-3
DG
2
-14
AMP
46
2
RIG
43
2
XEL
39
3
Financhill
Back

United States Lime & Minerals Vs. Blueprint Medicines Industry Stock Comparison

Buy
56

USLM
United States Lime & Minerals

Last Price:
$121.83
Seasonality Move:
5.37%
Sell
43

BPMC
Blueprint Medicines

Last Price:
$102.47
Seasonality Move:
5.27%
Buy
56
United States Lime & Minerals (USLM) is a Buy

Is United States Lime & Minerals a Buy, Sell or Hold?

  • The current United States Lime & Minerals [USLM] share price is $120.58. The Score for USLM is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • USLM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $103.36. The Score for BPMC is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

USLM Stock Price Chart

What is United States Lime & Minerals's stock price today?

  • The United States Lime & Minerals share price today is $120.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and USLM is experiencing buying pressure, which is a positive indicator for future bullish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $103.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

USLM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.48 Sell
Relative Strength Index (14 RSI): 34.17 Sell
Chaikin Money Flow: 77637 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.37 - 145.61) Sell
Bollinger Bands (100): (87.58 - 139.92) Buy

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 65.19 Buy
Chaikin Money Flow: 1951173 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.25 - 95.81) Buy
Bollinger Bands (100): (87.04 - 95.76) Buy

USLM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 122.02 Sell
20-day SMA: 131.83 Sell
50-day SMA: 137.14 Sell
200-day SMA: 91.84 Buy
8-day EMA: 122.79 Sell
20-day EMA: 129.51 Sell
50-day EMA: 129.29 Sell
200-day EMA: 98.46 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.01 Buy
20-day SMA: 91.26 Buy
50-day SMA: 93.56 Buy
200-day SMA: 96.81 Buy
8-day EMA: 92.7 Buy
20-day EMA: 91.91 Buy
50-day EMA: 92.32 Buy
200-day EMA: 91.6 Buy

United States Lime & Minerals Earnings Growth & USLM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.

United States Lime & Minerals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):